Ishita Drugs & Industries Reports Strong Financial Growth in June 2025 Results
Ishita Drugs & Industries has announced its financial results for the quarter ending June 2025, highlighting significant growth. Key metrics include a Profit After Tax of Rs 0.30 crore, net sales of Rs 9.96 crore, and an Earnings per Share of Rs 1.00, indicating a strengthening financial position.
Ishita Drugs & Industries has recently reported its financial results for the quarter ending June 2025, showcasing notable developments within the company. The financial performance indicates a significant upward shift in its evaluation, with the score reflecting a change from 2 to 11 over the past three months.The quarter has marked a peak in several key metrics for Ishita Drugs. The Profit After Tax (PAT) reached Rs 0.30 crore, demonstrating consistent growth over the last five quarters. This positive trend is mirrored in the net sales, which totaled Rs 9.96 crore, representing a year-on-year growth of 32.27%. Additionally, the Operating Profit (PBDIT) also hit a high of Rs 0.35 crore, further emphasizing the company's strengthening financial position.
Moreover, the Profit Before Tax (PBT) recorded a quarterly high of Rs 0.30 crore, aligning with the overall positive trajectory observed in the company's financial indicators. The Earnings per Share (EPS) reached Rs 1.00, reflecting an increase in profitability and enhanced earnings for shareholders.
Overall, Ishita Drugs & Industries is experiencing a favorable financial landscape, as evidenced by these recent results.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
